Gitaloxin is a digitalis
glycoside used for the same indications as
digoxin and
digitoxin. The successful outcome for a 2 1/2-year-old boy who accidentally ingested 3 mg of
gitaloxin (100 times the normal therapeutic dose) is reported. At admission the child presented with irregular heart rhythm. He subsequently started
vomiting, even after continuous gastric feeding. Only 48 h after ingestion of
gitaloxin he became somnolent and developed
bradyarrhythmia. The symptoms disappeared 96 h later; the
bradyarrhythmia, however, (second-degree
atrioventricular block) decreased progressively only after 120 h. The initial clinical presentation of
gitaloxin poisoning may be misleading and careful observation in a pediatric intensive care unit is mandatory. A cross-reaction between the fluorescence polarization immunoassay for
digitoxin and the radioimmunoassay for
gitaloxin was found and was used as a helpful, but rough, estimate of the severity of
gitaloxin poisoning, in the absence of a specific measurement of
gitaloxin.